Wedbush continued its UnitedHealth UNH Buy rating and $60 price target in a research report published today.
In the report, Wedbush states, "[W]e continue to recommend UNH and view the stock as a top pick for long-term holders. We believe United is undervalued given its exposure to Medicare, Medicaid and HCIT growth."
Shares of UnitedHealth were trading at $55.84 at the time of posting, up 0.20% from Monday's market close.
Market News and Data brought to you by Benzinga APIs© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Comments
Loading...
date | ticker | name | Price Target | Upside/Downside | Recommendation | Firm |
---|
Benzinga simplifies the market for smarter investing
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.
Join Now: Free!
Already a member?Sign in